162 related articles for article (PubMed ID: 18929426)
1. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
Macías J; Recio E; Vispo E; Rivero A; López-Cortés LF; Ríos MJ; Merino D; González M; Barreiro P; de Lédinghen V; Quereda C; Pineda JA
J Hepatol; 2008 Dec; 49(6):916-22. PubMed ID: 18929426
[TBL] [Abstract][Full Text] [Related]
2. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
Vergara S; Macías J; Rivero A; Gutiérrez-Valencia A; González-Serrano M; Merino D; Ríos MJ; García-García JA; Camacho A; López-Cortés L; Ruiz J; de la Torre J; Viciana P; Pineda JA;
Clin Infect Dis; 2007 Oct; 45(8):969-74. PubMed ID: 17879910
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
[TBL] [Abstract][Full Text] [Related]
5. Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.
Tsertsvadze T; Dolmazashvili E; Abutidze A; Sharvadze L; Karchava M
Georgian Med News; 2008 Dec; (165):38-42. PubMed ID: 19124915
[TBL] [Abstract][Full Text] [Related]
6. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
Al-Mohri H; Cooper C; Murphy T; Klein MB
HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
8. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
[TBL] [Abstract][Full Text] [Related]
10. Assessment of allograft fibrosis by transient elastography and noninvasive biomarker scoring systems in liver transplant patients.
Beckebaum S; Iacob S; Klein CG; Dechêne A; Varghese J; Baba HA; Sotiropoulos GC; Paul A; Gerken G; Cicinnati VR
Transplantation; 2010 Apr; 89(8):983-93. PubMed ID: 20335832
[TBL] [Abstract][Full Text] [Related]
11. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
[TBL] [Abstract][Full Text] [Related]
12. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH
J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
[TBL] [Abstract][Full Text] [Related]
13. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
[TBL] [Abstract][Full Text] [Related]
14. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients.
Miailhes P; Pradat P; Chevallier M; Lacombe K; Bailly F; Cotte L; Trabaud MA; Boibieux A; Bottero J; Trepo C; Zoulim F
J Viral Hepat; 2011 Jan; 18(1):61-9. PubMed ID: 20196798
[TBL] [Abstract][Full Text] [Related]
15. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
[TBL] [Abstract][Full Text] [Related]
16. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
Gatti F; Nasta P; Loregian A; Puoti M; Matti A; Pagni S; de Requena DG; Prestini K; Parisi SG; Bonora S; Palù G; Carosi G
J Antimicrob Chemother; 2009 Mar; 63(3):575-8. PubMed ID: 19151039
[TBL] [Abstract][Full Text] [Related]
17. Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.
Berenguer J; Bellón JM; Miralles P; Alvarez E; Sánchez-Conde M; Cosín J; López JC; Alvarez F; Catalán P; Resino S
J Viral Hepat; 2007 Dec; 14(12):859-69. PubMed ID: 18070289
[TBL] [Abstract][Full Text] [Related]
18. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease.
Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917
[TBL] [Abstract][Full Text] [Related]
20. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]